Glen L Xiong, Ana-Maria Iosif, Alvaro D Gonzalezk, Alice Fisherk, MarieChristi Candido, Michelle M Burke, Debra R Kahn, Peter Yellowlees
{"title":"非同步远程精神治疗与同步远程精神治疗在熟练护理机构中的比较:一项随机对照非劣效性临床试验。","authors":"Glen L Xiong, Ana-Maria Iosif, Alvaro D Gonzalezk, Alice Fisherk, MarieChristi Candido, Michelle M Burke, Debra R Kahn, Peter Yellowlees","doi":"10.1016/j.jamda.2025.105753","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Comparison of asynchronous telepsychiatry (ATP) with traditional synchronous telepsychiatry (STP) in skilled nursing facilities (SNFs) in California, United States.</p><p><strong>Design: </strong>Patient-level randomized, controlled noninferiority trial.</p><p><strong>Setting and participants: </strong>A total of 235 residents aged ≥18 years from 9 SNFs were referred for psychiatric symptom or medication evaluations.</p><p><strong>Methods: </strong>Patients were individually randomized to receive ATP or STP. Visits were conducted at baseline and 1, 2, 3, 6, and 12 months. The primary outcome was change in psychiatric symptom severity from baseline to 6 months, using the clinician-rated Clinical Global Impressions (CGI) Severity of Illness scale, with a predetermined noninferiority margin of 0.5 points. Secondary analyses examined medication reduction recommendations. Data were analyzed using generalized linear mixed-effects models.</p><p><strong>Results: </strong>Both groups showed improvement in symptoms. At 6 months, the intention-to-treat analysis (113 ATP, 109 STP) showed an adjusted CGI change of -0.47 (95% CI -0.64 to -0.29) for ATP and -0.68 (95% CI -0.86 to -0.49) for STP, with a between-group difference of 0.21 (95% CI -0.04 to 0.47), supporting noninferiority. The per-protocol analysis (79 ATP, 68 STP) showed an adjusted CGI change of -0.47 (95% CI -0.67 to -0.28) for ATP and -0.74 (95% CI -0.96 to -0.53) for STP, with a difference of 0.27 (95% CI -0.02 to 0.56). Because the upper bound of the confidence interval (0.56) exceeded the noninferiority margin (0.5), the per-protocol analysis did not support the noninferiority hypothesis. Overall rates of antipsychotic and antidepressant reduction recommendations were similar (P = .35 and P = .12, respectively).</p><p><strong>Conclusions and implications: </strong>ATP was noninferior to STP in the intention-to-treat analysis but not in the per-protocol analysis, possibly due to the reduced sample size. ATP has significant implications for improving access to mental health care for patients within SNFs. Larger replication studies are warranted to validate and further refine these findings.</p>","PeriodicalId":17180,"journal":{"name":"Journal of the American Medical Directors Association","volume":" ","pages":"105753"},"PeriodicalIF":4.2000,"publicationDate":"2025-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Comparison of Asynchronous Telepsychiatry vs Synchronous Telepsychiatry (CATELEST) in Skilled Nursing Facilities: A Randomized Controlled Noninferiority Clinical Trial.\",\"authors\":\"Glen L Xiong, Ana-Maria Iosif, Alvaro D Gonzalezk, Alice Fisherk, MarieChristi Candido, Michelle M Burke, Debra R Kahn, Peter Yellowlees\",\"doi\":\"10.1016/j.jamda.2025.105753\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>Comparison of asynchronous telepsychiatry (ATP) with traditional synchronous telepsychiatry (STP) in skilled nursing facilities (SNFs) in California, United States.</p><p><strong>Design: </strong>Patient-level randomized, controlled noninferiority trial.</p><p><strong>Setting and participants: </strong>A total of 235 residents aged ≥18 years from 9 SNFs were referred for psychiatric symptom or medication evaluations.</p><p><strong>Methods: </strong>Patients were individually randomized to receive ATP or STP. Visits were conducted at baseline and 1, 2, 3, 6, and 12 months. The primary outcome was change in psychiatric symptom severity from baseline to 6 months, using the clinician-rated Clinical Global Impressions (CGI) Severity of Illness scale, with a predetermined noninferiority margin of 0.5 points. Secondary analyses examined medication reduction recommendations. Data were analyzed using generalized linear mixed-effects models.</p><p><strong>Results: </strong>Both groups showed improvement in symptoms. At 6 months, the intention-to-treat analysis (113 ATP, 109 STP) showed an adjusted CGI change of -0.47 (95% CI -0.64 to -0.29) for ATP and -0.68 (95% CI -0.86 to -0.49) for STP, with a between-group difference of 0.21 (95% CI -0.04 to 0.47), supporting noninferiority. The per-protocol analysis (79 ATP, 68 STP) showed an adjusted CGI change of -0.47 (95% CI -0.67 to -0.28) for ATP and -0.74 (95% CI -0.96 to -0.53) for STP, with a difference of 0.27 (95% CI -0.02 to 0.56). Because the upper bound of the confidence interval (0.56) exceeded the noninferiority margin (0.5), the per-protocol analysis did not support the noninferiority hypothesis. Overall rates of antipsychotic and antidepressant reduction recommendations were similar (P = .35 and P = .12, respectively).</p><p><strong>Conclusions and implications: </strong>ATP was noninferior to STP in the intention-to-treat analysis but not in the per-protocol analysis, possibly due to the reduced sample size. ATP has significant implications for improving access to mental health care for patients within SNFs. Larger replication studies are warranted to validate and further refine these findings.</p>\",\"PeriodicalId\":17180,\"journal\":{\"name\":\"Journal of the American Medical Directors Association\",\"volume\":\" \",\"pages\":\"105753\"},\"PeriodicalIF\":4.2000,\"publicationDate\":\"2025-07-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of the American Medical Directors Association\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.jamda.2025.105753\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"GERIATRICS & GERONTOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the American Medical Directors Association","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jamda.2025.105753","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GERIATRICS & GERONTOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
目的:比较美国加利福尼亚州熟练护理机构(snf)中异步远程精神病学(ATP)与传统同步远程精神病学(STP)的差异。设计:患者水平随机对照非劣效性试验。环境和参与者:来自9个snf的235名年龄≥18岁的居民被转介进行精神症状或药物评估。方法:患者随机接受ATP或STP治疗。在基线和1、2、3、6和12个月时进行访问。主要结局是精神病症状严重程度从基线到6个月的变化,使用临床医生评定的临床总体印象(CGI)疾病严重程度量表,预先确定的非劣效性边际为0.5分。二级分析检查了减少用药的建议。数据分析采用广义线性混合效应模型。结果:两组患者症状均有改善。在6个月时,意向治疗分析(113 ATP, 109 STP)显示ATP的校正CGI变化为-0.47 (95% CI -0.64至-0.29),STP的校正CGI变化为-0.68 (95% CI -0.86至-0.49),组间差异为0.21 (95% CI -0.04至0.47),支持非劣效性。按协议分析(79 ATP, 68 STP)显示,ATP的调整后CGI变化为-0.47 (95% CI -0.67至-0.28),STP的调整后CGI变化为-0.74 (95% CI -0.96至-0.53),差异为0.27 (95% CI -0.02至0.56)。由于置信区间的上界(0.56)超过了非劣效性边际(0.5),按方案分析不支持非劣效性假设。抗精神病药和抗抑郁药减少建议的总体比率相似(P = 0.35和P = 0.12)。结论和意义:ATP在意向治疗分析中不逊于STP,但在方案分析中却不逊于STP,可能是由于样本量减少。ATP对改善snf内患者获得精神卫生保健的机会具有重要意义。需要更大规模的重复研究来验证和进一步完善这些发现。
Comparison of Asynchronous Telepsychiatry vs Synchronous Telepsychiatry (CATELEST) in Skilled Nursing Facilities: A Randomized Controlled Noninferiority Clinical Trial.
Objective: Comparison of asynchronous telepsychiatry (ATP) with traditional synchronous telepsychiatry (STP) in skilled nursing facilities (SNFs) in California, United States.
Setting and participants: A total of 235 residents aged ≥18 years from 9 SNFs were referred for psychiatric symptom or medication evaluations.
Methods: Patients were individually randomized to receive ATP or STP. Visits were conducted at baseline and 1, 2, 3, 6, and 12 months. The primary outcome was change in psychiatric symptom severity from baseline to 6 months, using the clinician-rated Clinical Global Impressions (CGI) Severity of Illness scale, with a predetermined noninferiority margin of 0.5 points. Secondary analyses examined medication reduction recommendations. Data were analyzed using generalized linear mixed-effects models.
Results: Both groups showed improvement in symptoms. At 6 months, the intention-to-treat analysis (113 ATP, 109 STP) showed an adjusted CGI change of -0.47 (95% CI -0.64 to -0.29) for ATP and -0.68 (95% CI -0.86 to -0.49) for STP, with a between-group difference of 0.21 (95% CI -0.04 to 0.47), supporting noninferiority. The per-protocol analysis (79 ATP, 68 STP) showed an adjusted CGI change of -0.47 (95% CI -0.67 to -0.28) for ATP and -0.74 (95% CI -0.96 to -0.53) for STP, with a difference of 0.27 (95% CI -0.02 to 0.56). Because the upper bound of the confidence interval (0.56) exceeded the noninferiority margin (0.5), the per-protocol analysis did not support the noninferiority hypothesis. Overall rates of antipsychotic and antidepressant reduction recommendations were similar (P = .35 and P = .12, respectively).
Conclusions and implications: ATP was noninferior to STP in the intention-to-treat analysis but not in the per-protocol analysis, possibly due to the reduced sample size. ATP has significant implications for improving access to mental health care for patients within SNFs. Larger replication studies are warranted to validate and further refine these findings.
期刊介绍:
JAMDA, the official journal of AMDA - The Society for Post-Acute and Long-Term Care Medicine, is a leading peer-reviewed publication that offers practical information and research geared towards healthcare professionals in the post-acute and long-term care fields. It is also a valuable resource for policy-makers, organizational leaders, educators, and advocates.
The journal provides essential information for various healthcare professionals such as medical directors, attending physicians, nurses, consultant pharmacists, geriatric psychiatrists, nurse practitioners, physician assistants, physical and occupational therapists, social workers, and others involved in providing, overseeing, and promoting quality